Gryphon International Investment’s Boston Scientific BSX Stock Holding History

Gryphon International Investment’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$320K	Buy	+7,385	New	+$327K	1.09%	11

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Gryphon International Investment's BSX Position: Q3 2021 in Review

Gryphon International Investment opened a new position in Boston Scientific (BSX) in Q3 2021: 7,385 shares worth $320K. The stake represents 1.09% of the portfolio and ranks #11 among its holdings.

878 funds tracked by Wall St. Rank hold BSX as of Q3 2021.

Gryphon International Investment held 7,385 shares of Boston Scientific worth $320K as of Q3 2021.
Boston Scientific was a new Gryphon International Investment position in Q3 2021.
Boston Scientific made up 1.09% of Gryphon International Investment's portfolio in Q3 2021, its #11 holding.
878 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2021.

Based on Gryphon International Investment's 13F filing for Q3 2021, filed 9 Nov 2021.